From the Sector

• Producing fabric for medical gowns: Advanced barrier effect solutions support COVID-19 efforts

Huntsman Textile Effects and Bao Minh Textile, one of the largest and most modern woven fabric producers in Vietnam, are collaborating to produce fabric that meets the stringent performance standards required of isolation gowns. High-quality medical gowns are essential protective wear for healthcare workers combatting the global COVID-19 pandemic, but these are in short supply worldwide.

Bao Minh Textile will initially treat 760,000 meters of woven fabric with a carefully curated combination of Huntsman Textile Effects barrier effect solutions and auxiliaries. This fabric is sufficient to produce 345,000 high-grade isolation gowns.

Bao Minh Textile’s isolation gown fabric relies on a range of Huntsman pretreatment, dyeing and finishing solutions. These include CLARITE® ONE, an all-in-one pretreatment for peroxide bleaching; NOVACRON® and TERASIL® dyes; PHOBOL® CP-C, an excellent oil-, water- and stain-repellent finish; and PHOBOTEX® RSY, a non-fluorinated durable water repellent with extremely high washing resistance. PHOBOL® EXTENDER XAN is also applied to further increase wash durability.

Protective masks for Europe
With FleeceforEurope and Lindenpartner, Düsseldorf-based Kloepfel Group purchasing consultancy and Berlin-based industrial consultancy Bechinger & Heymann Holding plan to manufacture and distribute up to 50 million protection class FFP1 through FFP3 respiratory masks a month exclusively for the European market from the beginning of fall. And the primary focus will be on quality.
With protective masks – including those used in operating rooms – this quality is provided above all by  virus-absorbing nonwovens. And these will be manufactured by ‘FleeceforEurope’ using an Oerlikon Nonwoven meltblown system.
But masks effectively protecting against infections can only be guaranteed with the right quality. A crucial factor in this is the inside of the mask. Because the nonwoven used in protection class FFP1 through FFP3 respiratory masks plays a decisive role.
Here, the meltblown technology from Oerlikon Nonwoven will be deployed. In a special, patented process, the fibers laid into a nonwoven fabric during manufacture are subsequently electrostatically-charged, before the material is further processed downstream.

European market for protective masks with a promising future
Those responsible at Oerlikon Nonwoven and FleeceforEurope, which will primarily focus on producing high-end nonwovens, and Lindenpartner, which will manufacture and distribute the protective masks, are certain of one thing: the market for protective masks has a very promising long-term future in Europe.
What has been commonplace in Asia for many years now will also become normal in Europe. People will be increasingly wearing face masks when venturing out, in order to better protect themselves against health risks such as the current pandemic and also against increasing environmental pollution in the form of  fine particles and exhaust fumes in the future. A

Medical face masks from a vending machine
Mask producer Lindenpartner has already secured supplies of nonwovens and will be producing face masks for the European healthcare sector over the coming weeks. To fight the coronavirus pandemic, Lindenpartner is planning to install 100 self-service face mask vending machines in Germany over the next four weeks, positioning them in publicly-accessible places such as shopping centers and airports, for example.

• Fiber prices and demand under pressure due to COVID-19 crisis
• Measures to maintain operations and to protect employees, customers and suppliers implemented successfully
• Hygiene competence center established to produce personal protective equipment in the fight against COVID-19 pandemic
• Strategic investment projects in Brazil and Thailand progressing according to plan
• Management Board proposes not to distribute a dividend for 2019 – AGM rescheduled for June 18, 2020

In a historically difficult market environment with increased pressure on prices and volumes resulting from the COVID-19 crisis, the Lenzing Group held its ground well in the first quarter of 2020. Thanks to a diversified business model and its global footprint on the one hand, and the disciplined implementation of the sCore TEN corporate strategy on the other, the effect on the revenue and earnings development was partially offset.

In the first quarter of 2020, revenue declined by 16.7 percent in comparison with the prior-year quarter and amounted to EUR 466.3 mn. The main reason was the development of prices for standard viscose (due to significant overcapacity in the market) and other standard fibers. The impact of the COVID-19 crisis further increased pressure on prices and volumes. The prices for standard viscose dropped to a new all-time low of 9,150 RMB/ton by March 31 – up to 33 percent lower than in the prior-year quarter. The comparatively positive development of the specialty fiber business and slightly higher demand for fibers in the medical and hygiene segments partially offset the decline in revenue. The share of specialty fibers increased from 47.3 percent in the first quarter of the previous year to 60.9 percent. The earnings development reflects the decline in revenue: EBITDA (earnings before interest, tax, depreciation and amortization) decreased by 24.3 percent to EUR 69.6 mn. The EBITDA margin declined from 16.4 percent to 14.9 percent. Net profit for the period was down 58.6 percent to EUR 17.7 mn. Earnings per share amounted to EUR 0.84 compared with EUR 1.65 in the first quarter of the previous year.

Energiapura – Production of reusable, customised protective masks that are also fashion accessories

• The Italian company, a specialist manufacturer of functional sportswear, conducted research and began producing masks in response to the COVID-19 crisis
• Using Mimaki sublimation printers, the masks can be customised, getting away from their connotation with hospitals and transforming them into a fashion accessory

From functional sportswear to combatting the spread of the Coronavirus: Energiapura, an Italian company has developed a mask that meets the Class I medical device requirements. The EP PA 2020 (Energiapura Pure Air) facial device, optimised for air filtering and breathability, provides protection while working, and can be reused. But Energiapura has gone even further, branding and customising the masks with sublimation printing.
The EP PA 2020 mask, compliant with 93/42 EEC Medical Devices – Class I washable, meets the essential requirements of UNI EN 14683:2019. Having redirected the manufacturing process, Energiapura is now stepping up production levels to meet the rising demand from hospitals, pharmacies, chemists, companies and consumers.

Pure Air, Energiapura’s mask
The EP PA 2020 is based on a functional concept: protection, breathability and reusability are the main principles. EP PA 2020 is made up of three layers of fabric: the first, the outer layer, is DWR-treated polyester, the second is TNT polyester, providing a filtering function, and the third, which comes into contact with the face, is polyester containing special fibres, such as coolmax and carbon.  Therefore it can be reused via normal washing and steam ironing, which also sterilises it.
The CEO of Enegiapura, Alberto Olivietto explains the idea of the customisation of the mask: “We wanted to disassociate our masks from the hospital image. By decorating them with company branding and designs provided by customers.” This is where the Mimaki JV300 wide-format printer comes in.

In mid-March, CHT Germany GmbH, which specializes in specialty chemicals, took up production and distribution of hand disinfectant. Now the company is expanding its product portfolio by adding important medical supplies that can help fight Covid-19 (SARS-CoV-2). Starting immediately, CHT is providing its business customers with surface disinfectant, textile supplies for medical protective wear as well as supplies for test kits and face masks.

Following increased demand for disinfectant in the wake of the new coronavirus, the CHT Group began already a month and a half ago to produce hand disinfectant at its factory in Dußlingen. Since then, more of its factories around the world had joined in. Now the CHT Group is complementing this offering by producing its own surface disinfectant based on ethanol. As with the hand disinfectant, the production of the surface disinfectant received a special approval, based on the expanded general ruling by the German Federal Agency  for Chemicals (BAuA). Both types of disinfectant use publicly available standard formulas for alcohol-based disinfectant from the World Health Organization (WHO). The sale of CHT’s surface disinfectant, which is available in 5-, 10- and 30-liter canisters, is exclusively for use by industry customers.

In addition, the CHT Group is manufacturing a range of textile-relevant products that provide protection from Covid-19. These include functional supplies for face masks for medical protective wear, as well as flocking for test kits. Through these offerings, the CHT Group also wants to support the textile sector, which has been strongly affected by the crisis.

Center of competence for hygiene established in Wiener Neudorf to support Austria and the EU in the Covid-19 crisis for the industrial production of high-quality protective masks with a monthly capacity of 12 million pieces.

Lenzing AG and Palmers Textil AG found “Hygiene Austria LP GmbH”, in which Lenzing AG holds 50.1% and Palmers Textil AG 49.9%. The newly founded company will start producing and selling protective masks for the domestic and European markets from May 2020.

Over the past few weeks, Lenzing AG and Palmers Textil AG have invested several million euros in a modern production infrastructure at the Wiener Neudorf location and secured the corresponding raw materials for protective masks production. In a first step, the company produces so-called mouth-nose protective masks (MNS) and surgical protective masks of class EN14683. Hygiene Austria LP GmbH plans to increase its capacities to over 25 million masks per month over the next few weeks and to expand this business geographically as well.

The demand for high-quality MNS and respiratory masks for medical personnel is increasing rapidly, and there is real competition on the international market for these products. In order to sustainably secure domestic supply now and in the future and to strengthen the business location, the two companies Lenzing AG and Palmers Textil AG have now set a milestone with their own competence center for hygiene based in Austria.

Hygiene Austria LP GmbH thus makes a significant contribution to combating the Covid-19 pandemic and ensures the long-term supply of these critical goods in Austria in high quality.

• Antiviral properties of Sanitized® products on synthetics validated

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by
up to 99 %.

Swiss company SANITIZED AG announces the validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019). Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2. Patented technology featuring an ammonium silicate compound  is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology.

These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses. The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

Before a final product’s antiviral properties can be publicly promoted, viral tests must be performed in specialized laboratories. Compliance with local legal regulations is essential here. SANITIZED AG explicitly points out that this is standard procedure and has composed a preliminary Guide for Treating PPE (personal protective equipment) with biocide products.

Guide Link: https://campaign.sanitized.com/en/treatment-of-ppe-with-biocidal-products

Elevate Textiles, a global provider of advanced, high quality products and mission critical textile solutions is pleased to participate in the recently launched Gerber PPE Task Force. This industry-wide effort combines resources and expertise to support manufacturing operations and brands as they increase their production or transition their operations to produce personal protective equipment in the fight against COVID-19.
Elevate’s Burlington, American & Efird (A&E), and Gütermann brands provide critical barrier fabric and thread components used in the manufacturing of lifesaving PPE products including masks, isolation gowns and other medical garments.

"The only way to be successful during this difficult situation is to join forces and support one another," said Lenny Marano, VP of Product Management & Marketing for Automation Systems at Gerber Technology. "We are proud to have a global network of partners to support PPE production so that it's more widely available."

For over 40 years, Burlington has been in the Medical business manufacturing fabrics for use in operating theaters such as surgeon’s gowns, isolation gowns, sterilization wrapper packs, drapes, scrubs and lab coats. The Maxima® collection of fabrics is useful for reusable isolation and surgical gowns and meets AAMI standards for Levels 1-4 and FDA standards.

Brown Wrote to President Outlining Critical Steps White House can Take Now to Address Shortage of Personal Protective Equipment

 U.S. Sen. Sherrod Brown (D-OH) hosted a news conference call to discuss his plan for addressing the shortage of personal protective equipment (PPE) needed by healthcare workers on the frontline of keeping Americans healthy and safe during the coronavirus pandemic.

This weekend, Brown wrote to President Trump outlining several steps the Administration should take immediately to address the shortage and ramp up manufacturing of these critical medical supplies.

In his plan and in his letter to the President, Brown lists nine steps the Administration could take immediately, including:

1. Designate a government official who can serve as a point person responsible for coordination the acquisition and development of PPE, medical devices, and other supplies necessary to fight the coronavirus pandemic. 
2. Establish a PPE and medical device assessment and database to monitor the supply and anticipated needs for PPE, ventilators, diagnostic test kits, and other needed medical supplies to respond to the coronavirus pandemic. 
3. Publish a list of PPE, medical device, and general medical supply needs to respond to the coronavirus pandemic. 
4. Establish a hotline capable of handling significant call capacity that will provide U.S. producers centralized information about the results of the national assessment and the current need for PPE, devices, and other health care supplies. 
5. Provide immediate funding to manufacturers to purchase equipment, retool machinery, hire additional workers, and cover any other expenses needed to increase production of PPE and necessary medical devices and supplies.
6. Streamline contract and certification procedures to ensure production and delivery of materials are not delayed due to paperwork constraints.
7. Provide critical protections for workers who are making PPE, medical devices, and necessary supplies to receive a waiver from any shelter-in-place requirements to allow workers to volunteer to go to work in these critical industries. 
8. Provide purchase guarantees and delivery assistance of product to the communities and health care facilities that need the products most. 
9. Support companies that have the capacity to sterilize reusable equipment to alleviate the existing PPE shortage. 

In his plan, Brown also pointed out important legislative actions that will help ramp up production of these critical supplies, including expanding the strategic national stockpile authority, substantially increasing Defense Production Act funding and strengthening domestic preferences.

Textile and nonwoven associations issued a joint statement today urging federal, state and local governments to deem textile and nonwoven manufacturing facilities as “essential” when drafting “Shelter in Place” orders in response to the COVID-19 crisis.

Our associations recognize the serious challenges our elected officials, health administrators, and others are facing when issuing orders to protect communities across the country and we understand the necessity for leaders to enforce a ‘Shelter in Place” order or quarantine orders.

Our members make a broad range of inputs and finished products used in an array of personal protective equipment (PPE) and medical nonwoven/textile supplies, including surgical gowns, face masks, antibacterial wipes, lab coats, blood pressure cuffs, cotton swabs and hazmat suits. These items are vital to the government’s effort to ramp up emergency production of these critical supplies.

If workers who produce these goods are not granted an “essential” exemption from “Shelter in Place” and other quarantine orders to go to their manufacturing and distribution facilities, it will cause major disruptions in the availability of these goods. This will create significant hardship to healthcare providers and consumers across the country who depend on steady and stable supplies of these critical items.

We are asking the administration and state and local authorities to provide greater certainty and clarity for our companies and employees and ask for a clear exclusion of our manufacturing operations from “Shelter in Place” orders as the textile and nonwoven products that we make in the U.S. play an essential role in mitigating the shortages of critical supplies. Such a designation will help us avoid disruptions of vital goods and services during this challenging time.